MAMMOSCREEN takes part in the first Annual Meeting of the Cancer Mission Cluster “Prevention and early detection (Screening)” The first annual meeting of the “Prevention and early detection (screening)” Cluster…
MammoScreen launches the Hereditary Breast Cancer Questionnaire In August 2023, the Hereditary Breast Cancer Questionnaire was launched as part of the MammoScreen project that ELAROS is a part of. ELAROS worked…
ELAROS joins MammoScreen in organising webinar “Shaping the future of Breast Cancer screening: introducing the MammoScreen project” The first MammoScreen Webinar with Patient Advocates and Patient Advocay Groups was held on…
MAMMOSCREEN joins the cancer “Prevention and early detection (Screening)” cluster of EU funded projects It is with great pleasure that we announce that MAMMOSCREEN has joined the EU funded projects…
ROVER: ELAROS delivers an industrial visit to University of Florence ELAROS Director of Research and Development, Román Rocha Lawrence, delivered a two week industrial visit to the Università degli Studi…
MammoScreen holds its first in person consortium meeting On the 17th and 18th of May, ELAROS had the exciting opportunity to attend the first MammoScreen Consortium Meeting at London Southbank…
Mi-Trial Launches Innovative New Clinical Trials App And Portal To Improve Trial Participation And Outcomes Mi-Trial, a new company which has developed an innovative clinical trial companion system and app,…
ELAROS Appoints Scientific Director for New Innovate UK Project ELAROS is delighted to announce that Dr Thomas Richards will join the team from the 1st April 2022, in the new…
ELAROS to support a Joint PhD with the University of Leeds, the University of Manchester and the University of Liverpool ELAROS is delighted to be able to announce that we…
C19-YRS becomes the first Clinically Validated Outcome Measure for use in Long COVID Patients ELAROS is pleased to announce on behalf of our C19-YRS clinical partners the first global study…